Two Sigma Investments LP lessened its holdings in shares of Organigram Holdings Inc. (NASDAQ:OGI - Free Report) by 59.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 130,477 shares of the company's stock after selling 189,007 shares during the quarter. Two Sigma Investments LP owned 0.10% of Organigram worth $210,000 as of its most recent SEC filing.
Several other hedge funds have also added to or reduced their stakes in OGI. Two Sigma Securities LLC acquired a new stake in shares of Organigram in the 4th quarter valued at about $26,000. Oxford Asset Management LLP bought a new position in shares of Organigram in the 4th quarter valued at about $50,000. Cubist Systematic Strategies LLC grew its holdings in shares of Organigram by 210.7% in the 4th quarter. Cubist Systematic Strategies LLC now owns 45,095 shares of the company's stock valued at $73,000 after acquiring an additional 30,583 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Organigram by 13.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 359,739 shares of the company's stock valued at $579,000 after acquiring an additional 43,721 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership bought a new position in shares of Organigram in the 4th quarter valued at about $1,153,000. Institutional investors and hedge funds own 34.63% of the company's stock.
Organigram Trading Up 2.1%
Shares of NASDAQ OGI traded up $0.03 during mid-day trading on Monday, hitting $1.43. The company had a trading volume of 554,046 shares, compared to its average volume of 658,064. The company has a market capitalization of $191.45 million, a PE ratio of -3.76 and a beta of 1.37. The firm has a 50-day simple moving average of $1.21 and a two-hundred day simple moving average of $1.31. Organigram Holdings Inc. has a one year low of $0.85 and a one year high of $2.08.
Organigram Company Profile
(
Free Report)
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
See Also

Before you consider Organigram Global, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Organigram Global wasn't on the list.
While Organigram Global currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.